News
CRC risk in young adults: Not as high as previously reported
- Author:
- Roxanne Nelson, RN, BSN
Previous studies of colorectal cancer included carcinoid tumors as well as colorectal adenocarcinoma, which has inflated estimates of risk,...
News
COVID-19 vaccines: Safe for immunocompromised patients?
- Author:
- Roxanne Nelson, RN, BSN
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
News
Patients with cancer a ‘high priority’ for COVID-19 vaccine, says AACR task force
- Author:
- Roxanne Nelson, RN, BSN
“We conclude that patients with an active cancer should be considered for priority access to COVID-19 vaccination.”
News
Margetuximab approved for HER2-positive metastatic breast cancer
- Author:
- Roxanne Nelson, RN, BSN
The monoclonal antibody margetuximab-cmkb demonstrated superiority over trastuzumab.
News
COVID-19 vaccines: Safe for immunocompromised patients?
- Author:
- Roxanne Nelson, RN, BSN
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
News
Black race linked to poorer survival in AML
- Author:
- Roxanne Nelson, RN, BSN
The risk for death was 27% higher for Black patients compared with White patients.
News
No benefit from tranexamic acid prophylaxis in blood cancers
- Author:
- Roxanne Nelson, RN, BSN
The rate of occlusions in the central venous line was significantly higher for patients in the tranexamic acid...
News
Pembrolizumab ‘preferred choice’ in MSI-H/dMMR metastatic CRC
- Author:
- Roxanne Nelson, RN, BSN
Compared with chemotherapy, pembrolizumab doubled progression-free survival and improved the overall response rate in this patient population.
News
Practice-changing data at this year’s ASH meeting
- Author:
- Roxanne Nelson, RN, BSN
Like many other conferences this year, the ASH meeting will be virtual because of the continuing COVID-19...
News
New findings on ‘exceptional responders’ to cancer therapies
- Author:
- Roxanne Nelson, RN, BSN
Why do a small percentage of cancer patients show exceptional responses to therapy? The answer may lie in their genetic makeup.
News
Two-drug combo should be first-line standard of care in advanced endometrial cancer
- Author:
- Roxanne Nelson, RN, BSN
Survival outcomes for the combination paclitaxel-carboplatin were similar to those with paclitaxel, doxorubicin, and cisplatin but with lower...
News
Rare event: Iatrogenic injury during cervical cancer screening
- Author:
- Roxanne Nelson, RN, BSN
In rare instances, women with invasive cervical cancer experience medical complications during their diagnostic...
News
IMRT new standard of care for high-risk cervical cancer
- Author:
- Roxanne Nelson, RN, BSN
Intensity-modulated radiotherapy was as effective as three-dimensional conformal radiotherapy but was associated with significantly less morbidity...
News
SRS instead of WBRT for patients with multiple brain metastases
- Author:
- Roxanne Nelson, RN, BSN
Patients with more than four brain metastases experienced less neurocognitive deterioration if treated with...
News
Cancer therapy affects sexual health in most patients
- Author:
- Roxanne Nelson, RN, BSN
Most cancer survivors surveyed said their oncologists have not asked about their sexual health.